Levocetirizine
Levocetirizine
Xyzal, Xyzal Allergy 24HR (OTC)
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
No titration strategies yet. Be the first to suggest one.
Effects
No effects listed yet. Be the first to suggest one.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Common uses
Allergic rhinitis (seasonal and perennial)0, Chronic idiopathic urticaria0
Pharmacy
Starting dose
5 mg PO once daily in the evening
Preparations
5 mg tablets; 2.5 mg/5 mL oral solution; OTC
US FDA Max
5 mg/d (adults)
Pharmacology
Routes
Oral
Onset
30-60 minutes
Duration
24 hours
Half-life
~8 hours (longer in elderly and renal impairment)[1]
Bioavailability
~85-90% (oral; not significantly affected by food)[1]
Pregnancy
Generally considered safe; widely used. Cetirizine and loratadine remain the more-studied alternatives.[citation needed]
Legal status
OTC in US
Purported mechanism
Levocetirizine is the active R-enantiomer of racemic cetirizine; it binds H1 receptors with ~2× the affinity of the racemate at half the dose, with minimal CNS penetration and minimal anticholinergic burden.0 Mostly renally cleared unchanged; dose-reduce in renal impairment. Like cetirizine, retains slightly more sedation than fexofenadine in some users[1].
References
- ↑ 1.0 1.1 1.2 FDA Prescribing Information, Xyzal (levocetirizine dihydrochloride), Sanofi, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022064s016lbl.pdf